Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lagis Enterprise CoROCO:6730 -0.94%90 EV-to-EBIT is 14.37 as of Sep. 13, 2026, which is 64% below its 10-year median of 39.83. GuruFocus rates ROCO:6730 with a GF Score™ of 90/100 and a GF Value™ of NT$39.95 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 474 Medical Devices & Instruments companies, Lagis Enterprise Co ranks better than 59.92% on this metric.
The historical rank and industry rank for Lagis Enterprise Co's EV-to-EBIT or its related term are showing as below:
ROCO:6730'
s EV-to-EBIT Range Over the Past 10 Years
Min: 14.37 Med: 39.83 Max: 60.17
Current: 14.37
During the past 10 years, the highest EV-to-EBIT of Lagis Enterprise Co was 60.17. The lowest was 14.37. And the median was 39.83.
ROCO:6730's EV-to-EBIT is ranked better than 59.92% of 474
companies
in the Medical Devices & Instruments industry
Industry Median: 18.005
vs ROCO:6730: 14.37
Lagis Enterprise Co (ROCO:6730) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Lagis Enterprise Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$1,527.9 Mil.
Lagis Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$89.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lagis Enterprise Co EV-to-EBIT Related Terms
Lagis Enterprise Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Lagis Enterprise Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6730 vs ISRG, BDX, RMD: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Lagis Enterprise Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lagis Enterprise Co EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lagis Enterprise Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Lagis Enterprise Co's EV-to-EBIT falls into.
Lagis Enterprise Co's current Enterprise Value is NT$1,292.0 Mil.
Lagis Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$89.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lagis Enterprise Co (ROCO:6730) has a EV-to-EBIT of 14.37 as of Sep. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lagis Enterprise Co and its competitors. This is 64% below median its historical median of 39.83. Over the past decade, Lagis Enterprise Co's EV-to-EBIT has ranged from 14.37 to 60.17. According to the industry distribution chart, Lagis Enterprise Co ranks #190 out of 474 companies in the Medical Devices & Instruments industry, placing it in the top 40.1%.
Is Lagis Enterprise Co's EV-to-EBIT too high?
Lagis Enterprise Co's current EV-to-EBIT of 14.37 is 64% below median its 10-year median of 39.83. Over the past 10 years, this metric has ranged from a low of 14.37 to a high of 60.17. The Medical Devices & Instruments industry median EV-to-EBIT is 18.01. Lagis Enterprise Co's value of 14.37 is 20.2% below this industry median. Based on the distribution chart, Lagis Enterprise Co ranks #190 out of 474 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lagis Enterprise Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lagis Enterprise Co's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lagis Enterprise Co ranks #190 out of 474 companies for EV-to-EBIT. This puts Lagis Enterprise Co in the upper half of its industry. The industry median EV-to-EBIT is 18.01. Lagis Enterprise Co's value of 14.37 is 20.2% below this benchmark. Historically, Lagis Enterprise Co's own EV-to-EBIT has ranged from 14.37 to 60.17 over the past decade. While the company's 10-year median is 39.83 vs. the industry median of 18.01, Lagis Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.01, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lagis Enterprise Co's current EV-to-EBIT of 14.37 is 20.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lagis Enterprise Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lagis Enterprise Co's current EV-to-EBIT is 14.37, which is 64% below median its own 10-year median of 39.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lagis Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Lagis Enterprise Co (ROCO:6730) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.95, compared to a current price of NT$31.50 — trading 21.2% below its estimated fair value. The current EV-to-EBIT is 14.37, which is 64% below median its 10-year median of 39.83 and 20.2% below the Medical Devices & Instruments industry median of 18.01. Lagis Enterprise Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Lagis Enterprise Co (ROCO:6730), the current EV-to-EBIT is 14.37 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lagis Enterprise Co (ROCO:6730) Overvalued in 2026?
Based on GuruFocus' analysis, Lagis Enterprise Co stock appears to be undervalued.
The current stock price of NT$31.50 is trading 21.2% below its estimated GF Value™ of NT$39.95.
GuruFocus considers Lagis Enterprise Co to be Modestly Undervalued.
Key valuation signals for ROCO:6730:
EV-to-EBIT: 14.37 (64% below median its 10-year median of 39.83)
GF Value™: NT$39.95 vs. price of NT$31.50 (21.2% below fair value)
Industry Position: 20.2% below the Medical Devices & Instruments median (#190 of 474)
No single metric tells the full story. See the ROCO:6730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lagis Enterprise Co Ltd is a medical device development company that designs, patents, and markets medical devices for the laparoscopic and endoscopic surgical markets. Its product portfolio includes Access, Endo Devices, Specimen Retrieval products, Suction Irrigation systems, Training systems, and accessories.
90GF Score
Get the complete analysis for ROCO:6730
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6730 has been successfully added to your 
